These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39192568)

  • 21. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
    Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
    J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
    Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
    BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.
    Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive comparison of the prognostic value of systemic inflammation biomarkers for cancer cachexia: a multicenter prospective study.
    Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Lin S; Song M; Zhang X; Liu X; Yang M; Tang M; Song CH; Deng L; Shi H
    Inflamm Res; 2022 Nov; 71(10-11):1305-1313. PubMed ID: 35962796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors.
    He X; Li JP; Liu XH; Zhang JP; Zeng QY; Chen H; Chen SL
    J Cancer; 2018; 9(10):1877-1884. PubMed ID: 29805715
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer.
    Liu Z; Jin K; Guo M; Long J; Liu L; Liu C; Xu J; Ni Q; Luo G; Yu X
    Ann Surg Oncol; 2017 Feb; 24(2):561-568. PubMed ID: 27650825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score.
    Douglas E; McMillan DC
    Cancer Treat Rev; 2014 Jul; 40(6):685-91. PubMed ID: 24321611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia.
    Arai H; Maeda K; Wakabayashi H; Naito T; Konishi M; Assantachai P; Auyeung WT; Chalermsri C; Chen W; Chew J; Chou MY; Hsu CC; Hum A; Hwang IG; Kaido T; Kang L; Kamaruzzaman SB; Kim M; Lee JSW; Lee WJ; Liang CK; Lim WS; Lim JY; Lim YP; Lo RS; Ong T; Pan WH; Peng LN; Pramyothin P; Razalli NH; Saitoh M; Shahar S; Shi HP; Tung HH; Uezono Y; von Haehling S; Won CW; Woo J; Chen LK
    J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):1949-1958. PubMed ID: 37667992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study.
    Zhang Q; Song MM; Zhang X; Ding JS; Ruan GT; Zhang XW; Liu T; Yang M; Ge YZ; Tang M; Li XR; Qian L; Song CH; Xu HX; Shi HP
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1466-1476. PubMed ID: 34337882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report.
    Del Fabbro E; Hui D; Nooruddin ZI; Dalal S; Dev R; Freer G; Roberts L; Palmer JL; Bruera E
    J Pain Symptom Manage; 2010 Jun; 39(6):1016-24. PubMed ID: 20457506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between AWGC-cachexia and GLIM-malnutrition in patients with gastric cancer.
    Wang SL; Zhang FM; Chen CB; Dong QT; Liu S; Yu Z; Shen X; Zhuang CL
    Eur J Surg Oncol; 2024 Oct; 50(10):108580. PubMed ID: 39116516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation between a chronic inflammatory marker Tartrate-resistant acid phosphatase 5a with cancer cachexia.
    Wu YY; Chao TY; Liu HY; Huang TC; Chen JH; Dai MS; Janckila A; Lai SW; Chang PY
    J BUON; 2015; 20(1):325-31. PubMed ID: 25778334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The C-Reactive Protein/Albumin Ratio Is Useful for Predicting Short-Term Survival in Cancer and Noncancer Patients.
    Miyamoto T; Fujitani M; Fukuyama H; Hatanaka S; Koizumi Y; Kawabata A
    J Palliat Med; 2019 May; 22(5):532-537. PubMed ID: 30570426
    [No Abstract]   [Full Text] [Related]  

  • 36. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
    Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F
    Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.
    Zhang H; Shi J; Xie H; Liu X; Ruan G; Lin S; Ge Y; Liu C; Chen Y; Zheng X; Song M; Yang M; Zhang X; Shi HP
    Nutrition; 2023 Dec; 116():112191. PubMed ID: 37716090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and prognosis of cachexia according to the Asian Working Group for Cachexia criteria in sarcopenic dysphagia: A retrospective cohort study.
    Wakabayashi H; Kakehi S; Mizuno S; Kinoshita T; Toga S; Ohtsu M; Nishioka S; Momosaki R
    Nutrition; 2024 Jun; 122():112385. PubMed ID: 38428221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging markers of cancer cachexia and their relationship to sarcopenia.
    Lipshitz M; Visser J; Anderson R; Nel DG; Smit T; Steel HC; Rapoport B
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17511-17527. PubMed ID: 37906352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of anthropometry-based and bio-electrical impedance-based muscle-mass indicators in the Global Leadership Initiative on Malnutrition criteria for predicting prognosis in patients with cancer.
    Xie H; Wei L; Ruan G; Zhang H; Shi J; Lin S; Liu C; Liu X; Zheng X; Chen Y; Shi H
    Clin Nutr; 2024 Jul; 43(7):1791-1799. PubMed ID: 38865763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.